Cultural Aesthetics · Clinical Guide
East Asian facial aesthetics.
What most injectors miss.
I have been injecting patients for over 16 years — roughly half of that in Taiwan, half in Canada. The most consistent thing I have noticed is not that East Asian faces are fundamentally different. It is that injectors who have only ever treated one population tend to make assumptions that do not hold when they sit down in front of the other.
This is not a criticism. It is a structural problem. If you trained in a predominantly Caucasian clinical environment, that is your reference for what normal looks like, what natural looks like, and what the goal is. When a patient with a different facial structure and a different aesthetic framework sits down in front of you, your training is still pulling you toward the same defaults — even when those defaults do not apply.
This guide is an attempt to make some of those differences explicit. It is not a comprehensive anatomical textbook. It is the clinical perspective of a physician who has worked on both sides of that divide for a long time.
"Natural looks different on different faces. The injector's job is to understand what natural looks like for the specific patient in front of them — not to apply a universal template and call it restraint."
Anatomical differences that matter clinically
Individual variation is wide within any ethnic group, and generalizations carry real risks. With that said, there are population-level anatomical patterns that an experienced injector working across both East Asian and non-East Asian patient populations will encounter consistently. Ignoring them does not make them go away — it just means you are not accounting for them in your treatment planning.
| Feature | Common pattern in East Asian patients | Clinical implication |
|---|---|---|
| Bone structure | Wider zygoma, flatter midface projection, broader lower face | Cheek filler placement must account for existing width — lateral projection can worsen rather than improve balance |
| Masseter muscle | Often more developed, contributing to lower face width | Masseter reduction with neurotoxin is among the most commonly requested treatments; requires careful dosing to avoid asymmetry |
| Nasal structure | Lower dorsal height, wider alar base, less tip projection on average | Non-surgical rhinoplasty goals differ significantly — adding height vs. refining shape vs. narrowing are distinct requests with different techniques |
| Upper eyelid | Higher rate of monolid or low crease; levator insertion depth differs | Brow treatment must account for whether the frontalis is compensating for ptosis — treating the forehead without assessing this can cause brow drop |
| Periorbital fat | More prominent periorbital fat pads in many patients | Changes the appearance of upper eyelid fullness; filler in this area requires different depth and volume targets |
| Skin thickness | Tends to be thicker dermis with more sebaceous glands; ages differently | Tyndall effect risk from superficial HA filler is lower, but skin quality concerns (pores, texture) are often a higher priority than in other groups |
| Collagen loss pattern | Volume loss often appears later but temple and midface deflation still significant with age | Biostimulation timing and vial targets may differ; patients sometimes present later for treatment but with more structural deficit |
| Melanin content | Higher melanin; greater risk of post-inflammatory hyperpigmentation with some energy treatments | Laser and energy-based treatments require different settings and more cautious protocols; not relevant to injectables |
The brow and forehead problem
This is the area where I see the most mistakes, and the reason is specific. In patients with a heavier brow or upper lid — which is more common in East Asian patients — the frontalis muscle is often working overtime. It is lifting the brow compensating for the weight above. The patient has trained themselves to hold this position so habitually that neither they nor the injector notices it in consultation.
When you inject the forehead with neurotoxin to treat horizontal lines, you relax the frontalis. If the frontalis was compensating for a heavy brow, you have just removed the mechanism holding the brow up. The brow drops. The upper lid looks heavier. The patient looks tired, not refreshed — exactly the opposite of what they came for.
Anticipating this is not complicated once you know to look for it. The assessment is straightforward: observe whether the patient is habitually raising their brows, whether the brows sit at or below the orbital rim, and whether the upper lid has significant weight. If the frontalis is clearly compensating, you treat with great caution — or you do not treat the forehead at all until you have addressed the underlying issue.
This is not unique to East Asian patients. But it is a pattern I encounter more frequently in this population, and it is a pattern that injectors trained predominantly on a different patient population will sometimes miss because it falls outside their default reference range.
Aesthetic preferences worth understanding
Anatomy is one thing. Aesthetic preference is another. These are not the same, and conflating them leads to treatment plans that are anatomically appropriate but aesthetically wrong for the specific patient.
The following are generalizations — individual patients vary enormously — but they reflect patterns I encounter consistently enough to be worth naming explicitly.
Common mistakes worth naming
Over-projecting the lateral cheek
Adding volume to the lateral cheek to create "high cheekbones" in a patient who already has a wide zygoma widens the face further. The goal in many East Asian patients is midface volume, not lateral projection.
Treating the forehead without brow assessment
Relaxing a compensating frontalis causes brow drop and upper lid heaviness — the opposite of what most patients want. Assessment before treatment is non-negotiable.
Applying Caucasian lip ratios
The classic 1:1.6 upper-to-lower lip ratio is a Caucasian aesthetic standard. Applying it universally to patients with different baseline proportions produces results that look imposed rather than natural.
Under-dosing masseter reduction
The masseter tends to be more developed in East Asian patients on average. Injectors who dose for a standard masseter sometimes achieve inadequate results and attribute it to non-response rather than insufficient dosing.
Ignoring skin quality as the primary concern
When a patient's primary concern is skin texture and luminosity, leading with volume restoration treats the wrong problem. Assessment should establish what the patient actually wants before deciding what to inject.
Assuming aesthetic goals without asking
Cultural background correlates with aesthetic preference but does not determine it. Every patient's goals should be elicited directly, not assumed from their appearance. This is true regardless of ethnic background.
Why this matters at Skin Trek
A significant portion of our patient population in Richmond Hill has East Asian heritage. The GTA is one of the most ethnically diverse metropolitan areas in the world, and the York Region area where we practice reflects that.
I practiced for a decade in Taiwan before moving to Canada. That experience is not a credential I mention for marketing purposes — it is the reason I understand what natural looks like on East Asian faces in a way that I could not have learned from a textbook or a course. It means my reference for normal is built from years of treating this population, not extrapolated from a different one.
At Skin Trek we also approach skin quality as a primary concern rather than an afterthought. Sculptra, mesotherapy, and PRP — all of which we offer — address the texture and luminosity concerns that many East Asian patients prioritise as much as or more than volume. The treatment plan starts from what the patient actually wants, not from what an injector trained on a different population assumes they should want.
Frequently asked questions
Is it safe to get Sculptra or fillers as an East Asian patient?
Yes. The safety profile of injectable treatments does not differ significantly by ethnicity for most products. The considerations are anatomical and aesthetic rather than safety-related — with the exception of energy-based treatments, where higher melanin content increases the risk of post-inflammatory hyperpigmentation and requires adjusted protocols.
Do I need to find an injector with experience in East Asian patients?
You need an injector who will treat your face as it actually is, not as a version of a different facial reference they are more familiar with. Experience with East Asian patients is one way to build that understanding — it is not the only way, but it is a meaningful signal worth asking about.
Is masseter reduction safe, and how many units does it take?
Masseter reduction with neurotoxin is safe and well-established. The dosing varies considerably by patient — the masseter is a powerful muscle and in patients where it is more developed, achieving meaningful reduction typically requires 40 to 60 units of Botox equivalent per side, sometimes more. Under-dosing is a common reason for unsatisfactory results.
Can Sculptra address my skin quality concerns?
Yes, and this is an underappreciated benefit of Sculptra. Because it stimulates collagen throughout the dermis, patients consistently report improvements in skin texture, firmness, and overall luminosity alongside the volume restoration. For patients where skin quality is the primary concern, Sculptra is often a better starting point than fillers.
Every face is assessed individually. If you have questions about how your specific anatomy and goals should guide your treatment plan, a free consultation is the right place to start.
Book a Free Consultation ← The Nerd SectionRelated at Skin Trek
Sculptra vs. Fillers Sculptra Toronto How to Choose an Injector Botox Richmond Hill